Alyeska Investment Group
AMPH icon

Alyeska Investment Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Alyeska Investment Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-173,062
Closed -$3.04M – 463
2015
Q2 		$3.04M Buy
173,062
+12,656
+8% +$197K 0.03% 312
2015
Q1 		$2.4M Buy
160,406
+44,218
+38% +$591K 0.03% 351
2014
Q4 		$1.35M Buy
116,188
+17,214
+17% +$187K 0.02% 372
2014
Q3 		$1.15M Sell
98,974
-1,026
-1% -$10.7K 0.02% 316
2014
Q2 		$1M Buy
+100,000
New +$982K 0.02% 353

Other funds holding AMPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Alyeska Investment Group's AMPH Position: Q3 2015 in Review

Alyeska Investment Group sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2015, closing a stake of 173,062 shares — an estimated $3.04M sold.

Alyeska Investment Group first reported a position in AMPH in Q2 2014 and held it in 5 quarters. The position peaked at $3.04M in Q2 2015. 92 funds tracked by Wall St. Rank hold AMPH as of Q3 2015.

  • Alyeska Investment Group reported no remaining Amphastar Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Alyeska Investment Group sold 173,062 Amphastar Pharmaceuticals shares in Q3 2015, an estimated $3.04M.
  • Alyeska Investment Group first reported a position in Amphastar Pharmaceuticals in Q2 2014 and held it in 5 quarters.
  • Alyeska Investment Group's Amphastar Pharmaceuticals position peaked at $3.04M in Q2 2015.
  • 92 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2015.

Based on Alyeska Investment Group's 13F filing for Q3 2015, filed 16 Nov 2015.